nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—TPMT—Mercaptopurine—hematologic cancer	0.285	0.418	CbGbCtD
Bendroflumethiazide—CA1—Imatinib—hematologic cancer	0.0901	0.132	CbGbCtD
Bendroflumethiazide—CA1—Nilotinib—hematologic cancer	0.0819	0.12	CbGbCtD
Bendroflumethiazide—CA2—Imatinib—hematologic cancer	0.0779	0.114	CbGbCtD
Bendroflumethiazide—CA4—Nilotinib—hematologic cancer	0.077	0.113	CbGbCtD
Bendroflumethiazide—CA2—Nilotinib—hematologic cancer	0.0708	0.104	CbGbCtD
Bendroflumethiazide—TPMT—hematopoietic system—hematologic cancer	0.00334	0.0711	CbGeAlD
Bendroflumethiazide—KCNMA1—hematopoietic system—hematologic cancer	0.00311	0.0662	CbGeAlD
Bendroflumethiazide—SLC12A3—lung—hematologic cancer	0.00261	0.0556	CbGeAlD
Bendroflumethiazide—TPMT—gonad—hematologic cancer	0.00254	0.0541	CbGeAlD
Bendroflumethiazide—KCNMA1—gonad—hematologic cancer	0.00236	0.0503	CbGeAlD
Bendroflumethiazide—CA1—hematopoietic system—hematologic cancer	0.00236	0.0503	CbGeAlD
Bendroflumethiazide—TPMT—blood—hematologic cancer	0.00221	0.0471	CbGeAlD
Bendroflumethiazide—TPMT—bone marrow—hematologic cancer	0.00214	0.0456	CbGeAlD
Bendroflumethiazide—TPMT—lung—hematologic cancer	0.00194	0.0413	CbGeAlD
Bendroflumethiazide—TPMT—testis—hematologic cancer	0.00183	0.039	CbGeAlD
Bendroflumethiazide—KCNMA1—lung—hematologic cancer	0.00181	0.0384	CbGeAlD
Bendroflumethiazide—KCNMA1—testis—hematologic cancer	0.0017	0.0363	CbGeAlD
Bendroflumethiazide—CA1—blood—hematologic cancer	0.00156	0.0333	CbGeAlD
Bendroflumethiazide—CA2—hematopoietic system—hematologic cancer	0.00153	0.0326	CbGeAlD
Bendroflumethiazide—CA1—bone marrow—hematologic cancer	0.00151	0.0322	CbGeAlD
Bendroflumethiazide—CA1—lung—hematologic cancer	0.00137	0.0292	CbGeAlD
Bendroflumethiazide—TPMT—lymph node—hematologic cancer	0.00133	0.0282	CbGeAlD
Bendroflumethiazide—KCNMA1—lymph node—hematologic cancer	0.00123	0.0263	CbGeAlD
Bendroflumethiazide—CA4—blood—hematologic cancer	0.00122	0.026	CbGeAlD
Bendroflumethiazide—CA4—bone marrow—hematologic cancer	0.00118	0.0252	CbGeAlD
Bendroflumethiazide—CA4—lung—hematologic cancer	0.00107	0.0228	CbGeAlD
Bendroflumethiazide—Benzthiazide—CA9—hematologic cancer	0.00106	0.296	CrCbGaD
Bendroflumethiazide—CA2—blood—hematologic cancer	0.00101	0.0216	CbGeAlD
Bendroflumethiazide—CA4—testis—hematologic cancer	0.00101	0.0215	CbGeAlD
Bendroflumethiazide—CA2—bone marrow—hematologic cancer	0.000981	0.0209	CbGeAlD
Bendroflumethiazide—CA1—lymph node—hematologic cancer	0.000938	0.02	CbGeAlD
Bendroflumethiazide—CA2—lung—hematologic cancer	0.000889	0.0189	CbGeAlD
Bendroflumethiazide—Hydroflumethiazide—CA9—hematologic cancer	0.000886	0.248	CrCbGaD
Bendroflumethiazide—Hydrochlorothiazide—CA9—hematologic cancer	0.000862	0.241	CrCbGaD
Bendroflumethiazide—CA2—testis—hematologic cancer	0.000838	0.0178	CbGeAlD
Bendroflumethiazide—Trichlormethiazide—CA9—hematologic cancer	0.000769	0.215	CrCbGaD
Bendroflumethiazide—CA4—lymph node—hematologic cancer	0.000733	0.0156	CbGeAlD
Bendroflumethiazide—CA2—lymph node—hematologic cancer	0.000608	0.0129	CbGeAlD
Bendroflumethiazide—Muscle spasms—Etoposide—hematologic cancer	0.00018	0.000926	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Mitoxantrone—hematologic cancer	0.00018	0.000926	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Irinotecan—hematologic cancer	0.00018	0.000926	CcSEcCtD
Bendroflumethiazide—Anorexia—Vincristine—hematologic cancer	0.00018	0.000925	CcSEcCtD
Bendroflumethiazide—Rash—Imatinib—hematologic cancer	0.000179	0.000923	CcSEcCtD
Bendroflumethiazide—Dermatitis—Imatinib—hematologic cancer	0.000179	0.000922	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Thalidomide—hematologic cancer	0.000179	0.00092	CcSEcCtD
Bendroflumethiazide—Asthenia—Lenalidomide—hematologic cancer	0.000178	0.000915	CcSEcCtD
Bendroflumethiazide—Vomiting—Cladribine—hematologic cancer	0.000177	0.000914	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Prednisone—hematologic cancer	0.000177	0.000913	CcSEcCtD
Bendroflumethiazide—Dizziness—Vinblastine—hematologic cancer	0.000177	0.000912	CcSEcCtD
Bendroflumethiazide—Hypotension—Vincristine—hematologic cancer	0.000176	0.000907	CcSEcCtD
Bendroflumethiazide—Rash—Cladribine—hematologic cancer	0.000176	0.000907	CcSEcCtD
Bendroflumethiazide—Dermatitis—Cladribine—hematologic cancer	0.000176	0.000906	CcSEcCtD
Bendroflumethiazide—Constipation—Thalidomide—hematologic cancer	0.000176	0.000905	CcSEcCtD
Bendroflumethiazide—Asthenia—Hydroxyurea—hematologic cancer	0.000175	0.000902	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Gemcitabine—hematologic cancer	0.000175	0.000902	CcSEcCtD
Bendroflumethiazide—Anorexia—Irinotecan—hematologic cancer	0.000175	0.000901	CcSEcCtD
Bendroflumethiazide—Anorexia—Mitoxantrone—hematologic cancer	0.000175	0.000901	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Melphalan—hematologic cancer	0.000174	0.000898	CcSEcCtD
Bendroflumethiazide—Nausea—Chlorambucil—hematologic cancer	0.000173	0.000894	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Carmustine—hematologic cancer	0.000172	0.000884	CcSEcCtD
Bendroflumethiazide—Hypotension—Mitoxantrone—hematologic cancer	0.000171	0.000883	CcSEcCtD
Bendroflumethiazide—Hypotension—Irinotecan—hematologic cancer	0.000171	0.000883	CcSEcCtD
Bendroflumethiazide—Anorexia—Gemcitabine—hematologic cancer	0.00017	0.000878	CcSEcCtD
Bendroflumethiazide—Vomiting—Vinblastine—hematologic cancer	0.00017	0.000877	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Alitretinoin—hematologic cancer	0.00017	0.000876	CcSEcCtD
Bendroflumethiazide—Nausea—Nilotinib—hematologic cancer	0.00017	0.000874	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Lenalidomide—hematologic cancer	0.000169	0.000873	CcSEcCtD
Bendroflumethiazide—Constipation—Carmustine—hematologic cancer	0.000169	0.00087	CcSEcCtD
Bendroflumethiazide—Nausea—Imatinib—hematologic cancer	0.000169	0.000869	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Ifosfamide—hematologic cancer	0.000168	0.000865	CcSEcCtD
Bendroflumethiazide—Constipation—Alitretinoin—hematologic cancer	0.000167	0.000861	CcSEcCtD
Bendroflumethiazide—Purpura—Doxorubicin—hematologic cancer	0.000167	0.000861	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Hydroxyurea—hematologic cancer	0.000167	0.000861	CcSEcCtD
Bendroflumethiazide—Hypotension—Gemcitabine—hematologic cancer	0.000167	0.00086	CcSEcCtD
Bendroflumethiazide—Nausea—Cladribine—hematologic cancer	0.000166	0.000854	CcSEcCtD
Bendroflumethiazide—Constipation—Ifosfamide—hematologic cancer	0.000165	0.000851	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Vincristine—hematologic cancer	0.000164	0.000844	CcSEcCtD
Bendroflumethiazide—Dizziness—Lenalidomide—hematologic cancer	0.000164	0.000844	CcSEcCtD
Bendroflumethiazide—Asthenia—Bortezomib—hematologic cancer	0.000163	0.000842	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Cisplatin—hematologic cancer	0.000163	0.00084	CcSEcCtD
Bendroflumethiazide—Asthenia—Bleomycin—hematologic cancer	0.000162	0.000836	CcSEcCtD
Bendroflumethiazide—Vomiting—Melphalan—hematologic cancer	0.000162	0.000834	CcSEcCtD
Bendroflumethiazide—Dizziness—Hydroxyurea—hematologic cancer	0.000161	0.000832	CcSEcCtD
Bendroflumethiazide—Constipation—Vincristine—hematologic cancer	0.000161	0.00083	CcSEcCtD
Bendroflumethiazide—Rash—Melphalan—hematologic cancer	0.000161	0.000827	CcSEcCtD
Bendroflumethiazide—Dermatitis—Melphalan—hematologic cancer	0.00016	0.000826	CcSEcCtD
Bendroflumethiazide—Asthenia—Vinorelbine—hematologic cancer	0.00016	0.000822	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Mitoxantrone—hematologic cancer	0.000159	0.000822	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Irinotecan—hematologic cancer	0.000159	0.000822	CcSEcCtD
Bendroflumethiazide—Nausea—Vinblastine—hematologic cancer	0.000159	0.000819	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Epirubicin—hematologic cancer	0.000159	0.000819	CcSEcCtD
Bendroflumethiazide—Anorexia—Cisplatin—hematologic cancer	0.000159	0.000818	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Epirubicin—hematologic cancer	0.000158	0.000816	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Methotrexate—hematologic cancer	0.000158	0.000812	CcSEcCtD
Bendroflumethiazide—Vomiting—Lenalidomide—hematologic cancer	0.000157	0.000811	CcSEcCtD
Bendroflumethiazide—Constipation—Mitoxantrone—hematologic cancer	0.000157	0.000808	CcSEcCtD
Bendroflumethiazide—Constipation—Irinotecan—hematologic cancer	0.000157	0.000808	CcSEcCtD
Bendroflumethiazide—Rash—Lenalidomide—hematologic cancer	0.000156	0.000804	CcSEcCtD
Bendroflumethiazide—Dermatitis—Lenalidomide—hematologic cancer	0.000156	0.000804	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Bortezomib—hematologic cancer	0.000156	0.000803	CcSEcCtD
Bendroflumethiazide—Hypotension—Cisplatin—hematologic cancer	0.000156	0.000802	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Gemcitabine—hematologic cancer	0.000155	0.000801	CcSEcCtD
Bendroflumethiazide—Vomiting—Hydroxyurea—hematologic cancer	0.000155	0.0008	CcSEcCtD
Bendroflumethiazide—Rash—Hydroxyurea—hematologic cancer	0.000154	0.000793	CcSEcCtD
Bendroflumethiazide—Dermatitis—Hydroxyurea—hematologic cancer	0.000154	0.000792	CcSEcCtD
Bendroflumethiazide—Constipation—Gemcitabine—hematologic cancer	0.000153	0.000787	CcSEcCtD
Bendroflumethiazide—Asthenia—Thiotepa—hematologic cancer	0.000152	0.000785	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Vinorelbine—hematologic cancer	0.000152	0.000784	CcSEcCtD
Bendroflumethiazide—Nausea—Melphalan—hematologic cancer	0.000151	0.000779	CcSEcCtD
Bendroflumethiazide—Dizziness—Bortezomib—hematologic cancer	0.000151	0.000776	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Etoposide—hematologic cancer	0.000149	0.00077	CcSEcCtD
Bendroflumethiazide—Erectile dysfunction—Methotrexate—hematologic cancer	0.000148	0.000763	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Epirubicin—hematologic cancer	0.000147	0.00076	CcSEcCtD
Bendroflumethiazide—Asthenia—Thalidomide—hematologic cancer	0.000147	0.00076	CcSEcCtD
Bendroflumethiazide—Dizziness—Vinorelbine—hematologic cancer	0.000147	0.000758	CcSEcCtD
Bendroflumethiazide—Orthostatic hypotension—Doxorubicin—hematologic cancer	0.000147	0.000758	CcSEcCtD
Bendroflumethiazide—Nausea—Lenalidomide—hematologic cancer	0.000147	0.000758	CcSEcCtD
Bendroflumethiazide—Hypokalaemia—Doxorubicin—hematologic cancer	0.000147	0.000755	CcSEcCtD
Bendroflumethiazide—Anorexia—Etoposide—hematologic cancer	0.000145	0.00075	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Thiotepa—hematologic cancer	0.000145	0.000749	CcSEcCtD
Bendroflumethiazide—Nausea—Hydroxyurea—hematologic cancer	0.000145	0.000747	CcSEcCtD
Bendroflumethiazide—Vomiting—Bortezomib—hematologic cancer	0.000145	0.000746	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Cisplatin—hematologic cancer	0.000145	0.000746	CcSEcCtD
Bendroflumethiazide—Vomiting—Bleomycin—hematologic cancer	0.000144	0.000741	CcSEcCtD
Bendroflumethiazide—Rash—Bortezomib—hematologic cancer	0.000144	0.00074	CcSEcCtD
Bendroflumethiazide—Dermatitis—Bortezomib—hematologic cancer	0.000143	0.00074	CcSEcCtD
Bendroflumethiazide—Hypotension—Etoposide—hematologic cancer	0.000143	0.000735	CcSEcCtD
Bendroflumethiazide—Rash—Bleomycin—hematologic cancer	0.000143	0.000735	CcSEcCtD
Bendroflumethiazide—Dermatitis—Bleomycin—hematologic cancer	0.000142	0.000734	CcSEcCtD
Bendroflumethiazide—Asthenia—Carmustine—hematologic cancer	0.000142	0.00073	CcSEcCtD
Bendroflumethiazide—Vomiting—Vinorelbine—hematologic cancer	0.000141	0.000729	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Thalidomide—hematologic cancer	0.000141	0.000724	CcSEcCtD
Bendroflumethiazide—Dizziness—Thiotepa—hematologic cancer	0.00014	0.000724	CcSEcCtD
Bendroflumethiazide—Asthenia—Alitretinoin—hematologic cancer	0.00014	0.000723	CcSEcCtD
Bendroflumethiazide—Rash—Vinorelbine—hematologic cancer	0.00014	0.000723	CcSEcCtD
Bendroflumethiazide—Dermatitis—Vinorelbine—hematologic cancer	0.00014	0.000722	CcSEcCtD
Bendroflumethiazide—Asthenia—Ifosfamide—hematologic cancer	0.000139	0.000714	CcSEcCtD
Bendroflumethiazide—Pancreatitis—Doxorubicin—hematologic cancer	0.000136	0.000703	CcSEcCtD
Bendroflumethiazide—Dizziness—Thalidomide—hematologic cancer	0.000136	0.0007	CcSEcCtD
Bendroflumethiazide—Nausea—Bortezomib—hematologic cancer	0.000135	0.000697	CcSEcCtD
Bendroflumethiazide—Asthenia—Vincristine—hematologic cancer	0.000135	0.000696	CcSEcCtD
Bendroflumethiazide—Vomiting—Thiotepa—hematologic cancer	0.000135	0.000696	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Carmustine—hematologic cancer	0.000135	0.000696	CcSEcCtD
Bendroflumethiazide—Nausea—Bleomycin—hematologic cancer	0.000134	0.000692	CcSEcCtD
Bendroflumethiazide—Rash—Thiotepa—hematologic cancer	0.000134	0.00069	CcSEcCtD
Bendroflumethiazide—Dermatitis—Thiotepa—hematologic cancer	0.000134	0.00069	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Alitretinoin—hematologic cancer	0.000134	0.000689	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Etoposide—hematologic cancer	0.000133	0.000684	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Ifosfamide—hematologic cancer	0.000132	0.000681	CcSEcCtD
Bendroflumethiazide—Nausea—Vinorelbine—hematologic cancer	0.000132	0.000681	CcSEcCtD
Bendroflumethiazide—Asthenia—Mitoxantrone—hematologic cancer	0.000132	0.000678	CcSEcCtD
Bendroflumethiazide—Asthenia—Irinotecan—hematologic cancer	0.000132	0.000678	CcSEcCtD
Bendroflumethiazide—Vomiting—Thalidomide—hematologic cancer	0.000131	0.000673	CcSEcCtD
Bendroflumethiazide—Dizziness—Carmustine—hematologic cancer	0.00013	0.000672	CcSEcCtD
Bendroflumethiazide—Constipation—Etoposide—hematologic cancer	0.00013	0.000672	CcSEcCtD
Bendroflumethiazide—Rash—Thalidomide—hematologic cancer	0.00013	0.000668	CcSEcCtD
Bendroflumethiazide—Dermatitis—Thalidomide—hematologic cancer	0.000129	0.000667	CcSEcCtD
Bendroflumethiazide—Dizziness—Alitretinoin—hematologic cancer	0.000129	0.000666	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Vincristine—hematologic cancer	0.000129	0.000664	CcSEcCtD
Bendroflumethiazide—Asthenia—Gemcitabine—hematologic cancer	0.000128	0.000661	CcSEcCtD
Bendroflumethiazide—Dizziness—Ifosfamide—hematologic cancer	0.000128	0.000658	CcSEcCtD
Bendroflumethiazide—Nausea—Thiotepa—hematologic cancer	0.000126	0.00065	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Irinotecan—hematologic cancer	0.000126	0.000647	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Mitoxantrone—hematologic cancer	0.000126	0.000647	CcSEcCtD
Bendroflumethiazide—Vomiting—Carmustine—hematologic cancer	0.000125	0.000647	CcSEcCtD
Bendroflumethiazide—Dizziness—Vincristine—hematologic cancer	0.000125	0.000642	CcSEcCtD
Bendroflumethiazide—Rash—Carmustine—hematologic cancer	0.000124	0.000641	CcSEcCtD
Bendroflumethiazide—Dermatitis—Carmustine—hematologic cancer	0.000124	0.000641	CcSEcCtD
Bendroflumethiazide—Vomiting—Alitretinoin—hematologic cancer	0.000124	0.000641	CcSEcCtD
Bendroflumethiazide—Rash—Alitretinoin—hematologic cancer	0.000123	0.000635	CcSEcCtD
Bendroflumethiazide—Dermatitis—Alitretinoin—hematologic cancer	0.000123	0.000635	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000123	0.000634	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Betamethasone—hematologic cancer	0.000123	0.000634	CcSEcCtD
Bendroflumethiazide—Vomiting—Ifosfamide—hematologic cancer	0.000123	0.000633	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Gemcitabine—hematologic cancer	0.000122	0.00063	CcSEcCtD
Bendroflumethiazide—Nausea—Thalidomide—hematologic cancer	0.000122	0.000629	CcSEcCtD
Bendroflumethiazide—Rash—Ifosfamide—hematologic cancer	0.000122	0.000628	CcSEcCtD
Bendroflumethiazide—Dermatitis—Ifosfamide—hematologic cancer	0.000122	0.000627	CcSEcCtD
Bendroflumethiazide—Dizziness—Irinotecan—hematologic cancer	0.000121	0.000625	CcSEcCtD
Bendroflumethiazide—Vomiting—Vincristine—hematologic cancer	0.00012	0.000617	CcSEcCtD
Bendroflumethiazide—Anorexia—Dexamethasone—hematologic cancer	0.00012	0.000617	CcSEcCtD
Bendroflumethiazide—Anorexia—Betamethasone—hematologic cancer	0.00012	0.000617	CcSEcCtD
Bendroflumethiazide—Asthenia—Cisplatin—hematologic cancer	0.000119	0.000616	CcSEcCtD
Bendroflumethiazide—Rash—Vincristine—hematologic cancer	0.000119	0.000612	CcSEcCtD
Bendroflumethiazide—Dermatitis—Vincristine—hematologic cancer	0.000119	0.000611	CcSEcCtD
Bendroflumethiazide—Hypotension—Dexamethasone—hematologic cancer	0.000117	0.000605	CcSEcCtD
Bendroflumethiazide—Hypotension—Betamethasone—hematologic cancer	0.000117	0.000605	CcSEcCtD
Bendroflumethiazide—Nausea—Carmustine—hematologic cancer	0.000117	0.000604	CcSEcCtD
Bendroflumethiazide—Vomiting—Irinotecan—hematologic cancer	0.000117	0.000601	CcSEcCtD
Bendroflumethiazide—Vomiting—Mitoxantrone—hematologic cancer	0.000117	0.000601	CcSEcCtD
Bendroflumethiazide—Nausea—Alitretinoin—hematologic cancer	0.000116	0.000598	CcSEcCtD
Bendroflumethiazide—Rash—Mitoxantrone—hematologic cancer	0.000116	0.000596	CcSEcCtD
Bendroflumethiazide—Rash—Irinotecan—hematologic cancer	0.000116	0.000596	CcSEcCtD
Bendroflumethiazide—Dermatitis—Mitoxantrone—hematologic cancer	0.000116	0.000596	CcSEcCtD
Bendroflumethiazide—Dermatitis—Irinotecan—hematologic cancer	0.000116	0.000596	CcSEcCtD
Bendroflumethiazide—Nausea—Ifosfamide—hematologic cancer	0.000115	0.000591	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Cisplatin—hematologic cancer	0.000114	0.000587	CcSEcCtD
Bendroflumethiazide—Vomiting—Gemcitabine—hematologic cancer	0.000114	0.000585	CcSEcCtD
Bendroflumethiazide—Rash—Gemcitabine—hematologic cancer	0.000113	0.000581	CcSEcCtD
Bendroflumethiazide—Dermatitis—Gemcitabine—hematologic cancer	0.000113	0.00058	CcSEcCtD
Bendroflumethiazide—Nausea—Vincristine—hematologic cancer	0.000112	0.000577	CcSEcCtD
Bendroflumethiazide—Asthenia—Etoposide—hematologic cancer	0.000109	0.000564	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Dexamethasone—hematologic cancer	0.000109	0.000563	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Betamethasone—hematologic cancer	0.000109	0.000563	CcSEcCtD
Bendroflumethiazide—Nausea—Irinotecan—hematologic cancer	0.000109	0.000562	CcSEcCtD
Bendroflumethiazide—Nausea—Mitoxantrone—hematologic cancer	0.000109	0.000562	CcSEcCtD
Bendroflumethiazide—Nausea—Gemcitabine—hematologic cancer	0.000106	0.000547	CcSEcCtD
Bendroflumethiazide—Vomiting—Cisplatin—hematologic cancer	0.000106	0.000546	CcSEcCtD
Bendroflumethiazide—Rash—Cisplatin—hematologic cancer	0.000105	0.000541	CcSEcCtD
Bendroflumethiazide—Dermatitis—Cisplatin—hematologic cancer	0.000105	0.000541	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Etoposide—hematologic cancer	0.000104	0.000538	CcSEcCtD
Bendroflumethiazide—Anorexia—Prednisone—hematologic cancer	0.000104	0.000537	CcSEcCtD
Bendroflumethiazide—Dizziness—Etoposide—hematologic cancer	0.000101	0.00052	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Epirubicin—hematologic cancer	0.000101	0.000519	CcSEcCtD
Bendroflumethiazide—Dizziness—Prednisolone—hematologic cancer	9.95e-05	0.000513	CcSEcCtD
Bendroflumethiazide—Asthenia—Triamcinolone—hematologic cancer	9.93e-05	0.000512	CcSEcCtD
Bendroflumethiazide—Nausea—Cisplatin—hematologic cancer	9.89e-05	0.00051	CcSEcCtD
Bendroflumethiazide—Vomiting—Etoposide—hematologic cancer	9.7e-05	0.0005	CcSEcCtD
Bendroflumethiazide—Rash—Etoposide—hematologic cancer	9.62e-05	0.000496	CcSEcCtD
Bendroflumethiazide—Dermatitis—Etoposide—hematologic cancer	9.61e-05	0.000495	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Prednisone—hematologic cancer	9.51e-05	0.00049	CcSEcCtD
Bendroflumethiazide—Rash—Prednisolone—hematologic cancer	9.49e-05	0.000489	CcSEcCtD
Bendroflumethiazide—Dermatitis—Prednisolone—hematologic cancer	9.48e-05	0.000489	CcSEcCtD
Bendroflumethiazide—Constipation—Prednisone—hematologic cancer	9.35e-05	0.000482	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Doxorubicin—hematologic cancer	9.32e-05	0.00048	CcSEcCtD
Bendroflumethiazide—Dizziness—Triamcinolone—hematologic cancer	9.15e-05	0.000472	CcSEcCtD
Bendroflumethiazide—Nausea—Etoposide—hematologic cancer	9.06e-05	0.000467	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—ITGA4—hematologic cancer	9.03e-05	0.00125	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Dexamethasone—hematologic cancer	9.01e-05	0.000464	CcSEcCtD
Bendroflumethiazide—Asthenia—Betamethasone—hematologic cancer	9.01e-05	0.000464	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Methotrexate—hematologic cancer	8.95e-05	0.000461	CcSEcCtD
Bendroflumethiazide—Nausea—Prednisolone—hematologic cancer	8.94e-05	0.000461	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—AGRN—hematologic cancer	8.87e-05	0.00123	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL3—hematologic cancer	8.8e-05	0.00122	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Triamcinolone—hematologic cancer	8.8e-05	0.000453	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNA1—hematologic cancer	8.74e-05	0.00121	CbGpPWpGaD
Bendroflumethiazide—Rash—Triamcinolone—hematologic cancer	8.73e-05	0.00045	CcSEcCtD
Bendroflumethiazide—Dermatitis—Triamcinolone—hematologic cancer	8.72e-05	0.000449	CcSEcCtD
Bendroflumethiazide—Anorexia—Methotrexate—hematologic cancer	8.71e-05	0.000449	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—HDC—hematologic cancer	8.67e-05	0.0012	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PTPN1—hematologic cancer	8.66e-05	0.0012	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CDA—hematologic cancer	8.63e-05	0.00119	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Betamethasone—hematologic cancer	8.59e-05	0.000443	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Dexamethasone—hematologic cancer	8.59e-05	0.000443	CcSEcCtD
Bendroflumethiazide—Hypotension—Methotrexate—hematologic cancer	8.54e-05	0.00044	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—RASGRP1—hematologic cancer	8.52e-05	0.00118	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SYK—hematologic cancer	8.49e-05	0.00117	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HMMR—hematologic cancer	8.41e-05	0.00116	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—IDH2—hematologic cancer	8.41e-05	0.00116	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Epirubicin—hematologic cancer	8.37e-05	0.000432	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—PC—hematologic cancer	8.31e-05	0.00115	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Dexamethasone—hematologic cancer	8.3e-05	0.000428	CcSEcCtD
Bendroflumethiazide—Dizziness—Betamethasone—hematologic cancer	8.3e-05	0.000428	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—CDA—hematologic cancer	8.27e-05	0.00114	CbGpPWpGaD
Bendroflumethiazide—Nausea—Triamcinolone—hematologic cancer	8.22e-05	0.000424	CcSEcCtD
Bendroflumethiazide—Anorexia—Epirubicin—hematologic cancer	8.15e-05	0.00042	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—IFNA2—hematologic cancer	8.14e-05	0.00112	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GBA—hematologic cancer	8.02e-05	0.00111	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC35B2—hematologic cancer	8.02e-05	0.00111	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—hematologic cancer	8.01e-05	0.00111	CbGpPWpGaD
Bendroflumethiazide—Hypotension—Epirubicin—hematologic cancer	7.99e-05	0.000412	CcSEcCtD
Bendroflumethiazide—Vomiting—Betamethasone—hematologic cancer	7.98e-05	0.000411	CcSEcCtD
Bendroflumethiazide—Vomiting—Dexamethasone—hematologic cancer	7.98e-05	0.000411	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—PC—hematologic cancer	7.96e-05	0.0011	CbGpPWpGaD
Bendroflumethiazide—Decreased appetite—Methotrexate—hematologic cancer	7.94e-05	0.000409	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—CDA—hematologic cancer	7.93e-05	0.0011	CbGpPWpGaD
Bendroflumethiazide—Rash—Dexamethasone—hematologic cancer	7.92e-05	0.000408	CcSEcCtD
Bendroflumethiazide—Rash—Betamethasone—hematologic cancer	7.92e-05	0.000408	CcSEcCtD
Bendroflumethiazide—Dermatitis—Dexamethasone—hematologic cancer	7.91e-05	0.000408	CcSEcCtD
Bendroflumethiazide—Dermatitis—Betamethasone—hematologic cancer	7.91e-05	0.000408	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—ARNTL—hematologic cancer	7.91e-05	0.00109	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—CREB1—hematologic cancer	7.87e-05	0.00109	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Prednisone—hematologic cancer	7.85e-05	0.000404	CcSEcCtD
Bendroflumethiazide—CA1—C-MYB transcription factor network—HRAS—hematologic cancer	7.81e-05	0.00108	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CYCS—hematologic cancer	7.8e-05	0.00108	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—BRAF—hematologic cancer	7.78e-05	0.00107	CbGpPWpGaD
Bendroflumethiazide—Thrombocytopenia—Doxorubicin—hematologic cancer	7.75e-05	0.000399	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GBA—hematologic cancer	7.69e-05	0.00106	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC35B2—hematologic cancer	7.69e-05	0.00106	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ACP5—hematologic cancer	7.69e-05	0.00106	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CA9—hematologic cancer	7.69e-05	0.00106	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—GRB2—hematologic cancer	7.66e-05	0.00106	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PDGFA—hematologic cancer	7.64e-05	0.00106	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PC—hematologic cancer	7.64e-05	0.00105	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOR2—hematologic cancer	7.59e-05	0.00105	CbGpPWpGaD
Bendroflumethiazide—Anorexia—Doxorubicin—hematologic cancer	7.54e-05	0.000389	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Prednisone—hematologic cancer	7.48e-05	0.000386	CcSEcCtD
Bendroflumethiazide—Nausea—Betamethasone—hematologic cancer	7.46e-05	0.000384	CcSEcCtD
Bendroflumethiazide—Nausea—Dexamethasone—hematologic cancer	7.46e-05	0.000384	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Epirubicin—hematologic cancer	7.43e-05	0.000383	CcSEcCtD
Bendroflumethiazide—Hypotension—Doxorubicin—hematologic cancer	7.39e-05	0.000381	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—GBA—hematologic cancer	7.37e-05	0.00102	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC35B2—hematologic cancer	7.37e-05	0.00102	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—JUN—hematologic cancer	7.36e-05	0.00102	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ABL1—hematologic cancer	7.36e-05	0.00102	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTAP—hematologic cancer	7.34e-05	0.00101	CbGpPWpGaD
Bendroflumethiazide—Constipation—Epirubicin—hematologic cancer	7.31e-05	0.000377	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—IDH1—hematologic cancer	7.23e-05	0.000999	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Prednisone—hematologic cancer	7.23e-05	0.000373	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—GSTO1—hematologic cancer	7.15e-05	0.000988	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—TXN—hematologic cancer	7.15e-05	0.000988	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCC3—hematologic cancer	7.15e-05	0.000988	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—PTEN—hematologic cancer	7.12e-05	0.000984	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTAP—hematologic cancer	7.04e-05	0.000972	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—SPHK1—hematologic cancer	7e-05	0.000967	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—MAPK8—hematologic cancer	6.97e-05	0.000962	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Prednisone—hematologic cancer	6.95e-05	0.000358	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—HGF—hematologic cancer	6.92e-05	0.000956	CbGpPWpGaD
Bendroflumethiazide—Rash—Prednisone—hematologic cancer	6.89e-05	0.000355	CcSEcCtD
Bendroflumethiazide—Dermatitis—Prednisone—hematologic cancer	6.89e-05	0.000355	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Doxorubicin—hematologic cancer	6.88e-05	0.000355	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—CSF2—hematologic cancer	6.84e-05	0.000945	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—EP300—hematologic cancer	6.79e-05	0.000938	CbGpPWpGaD
Bendroflumethiazide—Constipation—Doxorubicin—hematologic cancer	6.77e-05	0.000349	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—MTAP—hematologic cancer	6.74e-05	0.000932	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—UGT1A1—hematologic cancer	6.72e-05	0.000929	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PRKCG—hematologic cancer	6.6e-05	0.000912	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—JAK1—hematologic cancer	6.6e-05	0.000912	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Methotrexate—hematologic cancer	6.56e-05	0.000338	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—SLC22A1—hematologic cancer	6.54e-05	0.000903	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CRABP1—hematologic cancer	6.54e-05	0.000903	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—FHL2—hematologic cancer	6.54e-05	0.000903	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—MDM2—hematologic cancer	6.52e-05	0.0009	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ABCB1—hematologic cancer	6.51e-05	0.000899	CbGpPWpGaD
Bendroflumethiazide—Nausea—Prednisone—hematologic cancer	6.5e-05	0.000335	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—AGRN—hematologic cancer	6.41e-05	0.000886	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALOX5—hematologic cancer	6.37e-05	0.00088	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—FHL2—hematologic cancer	6.27e-05	0.000866	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Methotrexate—hematologic cancer	6.25e-05	0.000322	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—NUP98—hematologic cancer	6.17e-05	0.000853	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2RA—hematologic cancer	6.17e-05	0.000852	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AGRN—hematologic cancer	6.15e-05	0.000849	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Epirubicin—hematologic cancer	6.14e-05	0.000316	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—HMMR—hematologic cancer	6.08e-05	0.00084	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—IDH2—hematologic cancer	6.08e-05	0.00084	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Methotrexate—hematologic cancer	6.04e-05	0.000311	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—FHL2—hematologic cancer	6.01e-05	0.00083	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ADCY7—hematologic cancer	5.99e-05	0.000828	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOA3—hematologic cancer	5.99e-05	0.000828	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PDGFB—hematologic cancer	5.95e-05	0.000822	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NUP214—hematologic cancer	5.95e-05	0.000822	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AGRN—hematologic cancer	5.9e-05	0.000814	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Epirubicin—hematologic cancer	5.85e-05	0.000302	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—IDH2—hematologic cancer	5.83e-05	0.000805	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCG2—hematologic cancer	5.83e-05	0.000805	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTR—hematologic cancer	5.83e-05	0.000805	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HMMR—hematologic cancer	5.83e-05	0.000805	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Methotrexate—hematologic cancer	5.81e-05	0.000299	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—CDK2—hematologic cancer	5.78e-05	0.000798	CbGpPWpGaD
Bendroflumethiazide—Rash—Methotrexate—hematologic cancer	5.76e-05	0.000297	CcSEcCtD
Bendroflumethiazide—Dermatitis—Methotrexate—hematologic cancer	5.76e-05	0.000297	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—ARNTL—hematologic cancer	5.72e-05	0.00079	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ENO2—hematologic cancer	5.72e-05	0.00079	CbGpPWpGaD
Bendroflumethiazide—Asthenia—Doxorubicin—hematologic cancer	5.68e-05	0.000293	CcSEcCtD
Bendroflumethiazide—Dizziness—Epirubicin—hematologic cancer	5.66e-05	0.000291	CcSEcCtD
Bendroflumethiazide—CA1—Metabolism—IDH2—hematologic cancer	5.59e-05	0.000772	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HMMR—hematologic cancer	5.59e-05	0.000772	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CA9—hematologic cancer	5.56e-05	0.000768	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ACP5—hematologic cancer	5.56e-05	0.000768	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTT1—hematologic cancer	5.54e-05	0.000766	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAPK14—hematologic cancer	5.54e-05	0.000765	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOR2—hematologic cancer	5.49e-05	0.000758	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ARNTL—hematologic cancer	5.48e-05	0.000757	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Epirubicin—hematologic cancer	5.44e-05	0.00028	CcSEcCtD
Bendroflumethiazide—Nausea—Methotrexate—hematologic cancer	5.43e-05	0.00028	CcSEcCtD
Bendroflumethiazide—TPMT—Metabolism—SDC1—hematologic cancer	5.42e-05	0.000749	CbGpPWpGaD
Bendroflumethiazide—Diarrhoea—Doxorubicin—hematologic cancer	5.41e-05	0.000279	CcSEcCtD
Bendroflumethiazide—Rash—Epirubicin—hematologic cancer	5.39e-05	0.000278	CcSEcCtD
Bendroflumethiazide—Dermatitis—Epirubicin—hematologic cancer	5.39e-05	0.000278	CcSEcCtD
Bendroflumethiazide—KCNMA1—Hemostasis—FN1—hematologic cancer	5.37e-05	0.000742	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CA9—hematologic cancer	5.33e-05	0.000737	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ACP5—hematologic cancer	5.33e-05	0.000737	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOR2—hematologic cancer	5.26e-05	0.000727	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ARNTL—hematologic cancer	5.25e-05	0.000726	CbGpPWpGaD
Bendroflumethiazide—Dizziness—Doxorubicin—hematologic cancer	5.23e-05	0.00027	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—IDH1—hematologic cancer	5.23e-05	0.000722	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—TXN—hematologic cancer	5.17e-05	0.000714	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTO1—hematologic cancer	5.17e-05	0.000714	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCC3—hematologic cancer	5.17e-05	0.000714	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CG—hematologic cancer	5.14e-05	0.00071	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CA9—hematologic cancer	5.11e-05	0.000706	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ACP5—hematologic cancer	5.11e-05	0.000706	CbGpPWpGaD
Bendroflumethiazide—Nausea—Epirubicin—hematologic cancer	5.08e-05	0.000262	CcSEcCtD
Bendroflumethiazide—CA4—Metabolism—SPHK1—hematologic cancer	5.06e-05	0.000699	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PTPN11—hematologic cancer	5.05e-05	0.000697	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOR2—hematologic cancer	5.04e-05	0.000697	CbGpPWpGaD
Bendroflumethiazide—Vomiting—Doxorubicin—hematologic cancer	5.03e-05	0.000259	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—IDH1—hematologic cancer	5.01e-05	0.000692	CbGpPWpGaD
Bendroflumethiazide—Rash—Doxorubicin—hematologic cancer	4.99e-05	0.000257	CcSEcCtD
Bendroflumethiazide—Dermatitis—Doxorubicin—hematologic cancer	4.98e-05	0.000257	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—GSTO1—hematologic cancer	4.96e-05	0.000685	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCC3—hematologic cancer	4.96e-05	0.000685	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—TXN—hematologic cancer	4.96e-05	0.000685	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—UGT1A1—hematologic cancer	4.86e-05	0.000671	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—TP53—hematologic cancer	4.86e-05	0.000671	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SPHK1—hematologic cancer	4.85e-05	0.00067	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—IDH1—hematologic cancer	4.81e-05	0.000664	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—CREBBP—hematologic cancer	4.76e-05	0.000658	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCC3—hematologic cancer	4.75e-05	0.000656	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—TXN—hematologic cancer	4.75e-05	0.000656	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTO1—hematologic cancer	4.75e-05	0.000656	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CRABP1—hematologic cancer	4.73e-05	0.000653	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SLC22A1—hematologic cancer	4.73e-05	0.000653	CbGpPWpGaD
Bendroflumethiazide—Nausea—Doxorubicin—hematologic cancer	4.7e-05	0.000242	CcSEcCtD
Bendroflumethiazide—CA2—Metabolism—UGT1A1—hematologic cancer	4.66e-05	0.000644	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SPHK1—hematologic cancer	4.65e-05	0.000642	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NQO1—hematologic cancer	4.61e-05	0.000637	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CD44—hematologic cancer	4.61e-05	0.000637	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALOX5—hematologic cancer	4.61e-05	0.000637	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SLC22A1—hematologic cancer	4.53e-05	0.000626	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CRABP1—hematologic cancer	4.53e-05	0.000626	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CD—hematologic cancer	4.52e-05	0.000624	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—UGT1A1—hematologic cancer	4.47e-05	0.000617	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NUP98—hematologic cancer	4.46e-05	0.000617	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—ALB—hematologic cancer	4.46e-05	0.000616	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Circadian rythm related genes—IL6—hematologic cancer	4.45e-05	0.000615	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALOX5—hematologic cancer	4.42e-05	0.00061	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CYCS—hematologic cancer	4.36e-05	0.000602	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—CREBBP—hematologic cancer	4.35e-05	0.000601	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SLC22A1—hematologic cancer	4.35e-05	0.0006	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CRABP1—hematologic cancer	4.35e-05	0.0006	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ADCY7—hematologic cancer	4.33e-05	0.000598	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—HSP90AA1—hematologic cancer	4.33e-05	0.000598	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOA3—hematologic cancer	4.33e-05	0.000598	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NUP214—hematologic cancer	4.3e-05	0.000594	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NUP98—hematologic cancer	4.28e-05	0.000591	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3R1—hematologic cancer	4.27e-05	0.000589	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALOX5—hematologic cancer	4.24e-05	0.000585	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCG2—hematologic cancer	4.21e-05	0.000582	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTR—hematologic cancer	4.21e-05	0.000582	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ADCY7—hematologic cancer	4.15e-05	0.000574	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOA3—hematologic cancer	4.15e-05	0.000574	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—JAK2—hematologic cancer	4.15e-05	0.000573	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ENO2—hematologic cancer	4.13e-05	0.000571	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NUP214—hematologic cancer	4.12e-05	0.00057	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NUP98—hematologic cancer	4.1e-05	0.000567	CbGpPWpGaD
Bendroflumethiazide—SLC12A3—Transmembrane transport of small molecules—ALB—hematologic cancer	4.07e-05	0.000563	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCG2—hematologic cancer	4.04e-05	0.000558	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTR—hematologic cancer	4.04e-05	0.000558	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTT1—hematologic cancer	4.01e-05	0.000554	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ADCY7—hematologic cancer	3.98e-05	0.00055	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOA3—hematologic cancer	3.98e-05	0.00055	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ENO2—hematologic cancer	3.96e-05	0.000547	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NUP214—hematologic cancer	3.95e-05	0.000546	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CB—hematologic cancer	3.94e-05	0.000544	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—SDC1—hematologic cancer	3.92e-05	0.000541	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTR—hematologic cancer	3.87e-05	0.000535	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCG2—hematologic cancer	3.87e-05	0.000535	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTT1—hematologic cancer	3.84e-05	0.000531	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTP1—hematologic cancer	3.84e-05	0.000531	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ENO2—hematologic cancer	3.8e-05	0.000525	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—SDC1—hematologic cancer	3.76e-05	0.000519	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTT1—hematologic cancer	3.68e-05	0.000509	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ABCB1—hematologic cancer	3.64e-05	0.000503	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—IL2—hematologic cancer	3.62e-05	0.0005	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—SDC1—hematologic cancer	3.6e-05	0.000498	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Neuronal System—HRAS—hematologic cancer	3.58e-05	0.000494	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—GSTM1—hematologic cancer	3.53e-05	0.000488	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—NCOR1—hematologic cancer	3.53e-05	0.000488	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CD44—hematologic cancer	3.33e-05	0.00046	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NQO1—hematologic cancer	3.33e-05	0.00046	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—EP300—hematologic cancer	3.24e-05	0.000448	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CD44—hematologic cancer	3.19e-05	0.000441	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NQO1—hematologic cancer	3.19e-05	0.000441	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—SRC—hematologic cancer	3.16e-05	0.000436	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CYCS—hematologic cancer	3.15e-05	0.000435	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—HSP90AA1—hematologic cancer	3.13e-05	0.000433	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—MTHFR—hematologic cancer	3.12e-05	0.000431	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—VEGFA—hematologic cancer	3.07e-05	0.000425	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CD44—hematologic cancer	3.06e-05	0.000423	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NQO1—hematologic cancer	3.06e-05	0.000423	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—NRAS—hematologic cancer	3.04e-05	0.000419	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CYCS—hematologic cancer	3.02e-05	0.000418	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—HSP90AA1—hematologic cancer	3e-05	0.000415	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—MAPK3—hematologic cancer	2.91e-05	0.000402	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CYCS—hematologic cancer	2.9e-05	0.0004	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—HSP90AA1—hematologic cancer	2.88e-05	0.000398	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TGFB1—hematologic cancer	2.82e-05	0.00039	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTP1—hematologic cancer	2.78e-05	0.000384	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTP1—hematologic cancer	2.66e-05	0.000368	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ABCB1—hematologic cancer	2.63e-05	0.000363	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CG—hematologic cancer	2.62e-05	0.000362	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—KRAS—hematologic cancer	2.61e-05	0.000361	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTP1—hematologic cancer	2.55e-05	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—GSTM1—hematologic cancer	2.55e-05	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—NCOR1—hematologic cancer	2.55e-05	0.000353	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ABCB1—hematologic cancer	2.52e-05	0.000348	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—NCOR1—hematologic cancer	2.45e-05	0.000338	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—GSTM1—hematologic cancer	2.45e-05	0.000338	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—CREBBP—hematologic cancer	2.43e-05	0.000336	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ABCB1—hematologic cancer	2.42e-05	0.000334	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—PIK3CA—hematologic cancer	2.4e-05	0.000332	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—NCOR1—hematologic cancer	2.35e-05	0.000324	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—GSTM1—hematologic cancer	2.35e-05	0.000324	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—TP53—hematologic cancer	2.32e-05	0.000321	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CD—hematologic cancer	2.31e-05	0.000318	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—ALB—hematologic cancer	2.28e-05	0.000314	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—MTHFR—hematologic cancer	2.26e-05	0.000312	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—HRAS—hematologic cancer	2.22e-05	0.000307	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3R1—hematologic cancer	2.18e-05	0.000301	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—MTHFR—hematologic cancer	2.16e-05	0.000299	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—MTHFR—hematologic cancer	2.07e-05	0.000287	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CB—hematologic cancer	2.01e-05	0.000278	CbGpPWpGaD
Bendroflumethiazide—KCNMA1—Hemostasis—AKT1—hematologic cancer	1.96e-05	0.000271	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CG—hematologic cancer	1.9e-05	0.000262	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CG—hematologic cancer	1.82e-05	0.000251	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—CREBBP—hematologic cancer	1.76e-05	0.000243	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CG—hematologic cancer	1.74e-05	0.000241	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PTEN—hematologic cancer	1.74e-05	0.00024	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—CREBBP—hematologic cancer	1.69e-05	0.000233	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CD—hematologic cancer	1.67e-05	0.00023	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—EP300—hematologic cancer	1.66e-05	0.000229	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—ALB—hematologic cancer	1.65e-05	0.000227	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—CREBBP—hematologic cancer	1.62e-05	0.000223	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CD—hematologic cancer	1.6e-05	0.000221	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—ALB—hematologic cancer	1.58e-05	0.000218	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3R1—hematologic cancer	1.57e-05	0.000217	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CD—hematologic cancer	1.53e-05	0.000212	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—ALB—hematologic cancer	1.51e-05	0.000209	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3R1—hematologic cancer	1.51e-05	0.000208	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CB—hematologic cancer	1.45e-05	0.000201	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3R1—hematologic cancer	1.45e-05	0.0002	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CB—hematologic cancer	1.39e-05	0.000192	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CB—hematologic cancer	1.34e-05	0.000184	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PTEN—hematologic cancer	1.26e-05	0.000173	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—PIK3CA—hematologic cancer	1.22e-05	0.000169	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PTEN—hematologic cancer	1.2e-05	0.000166	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—EP300—hematologic cancer	1.2e-05	0.000165	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PTEN—hematologic cancer	1.15e-05	0.000159	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—EP300—hematologic cancer	1.15e-05	0.000159	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—EP300—hematologic cancer	1.1e-05	0.000152	CbGpPWpGaD
Bendroflumethiazide—TPMT—Metabolism—AKT1—hematologic cancer	1e-05	0.000138	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—PIK3CA—hematologic cancer	8.86e-06	0.000122	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—PIK3CA—hematologic cancer	8.49e-06	0.000117	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—PIK3CA—hematologic cancer	8.14e-06	0.000112	CbGpPWpGaD
Bendroflumethiazide—CA4—Metabolism—AKT1—hematologic cancer	7.23e-06	9.99e-05	CbGpPWpGaD
Bendroflumethiazide—CA2—Metabolism—AKT1—hematologic cancer	6.94e-06	9.58e-05	CbGpPWpGaD
Bendroflumethiazide—CA1—Metabolism—AKT1—hematologic cancer	6.65e-06	9.19e-05	CbGpPWpGaD
